anti-IL-7Ra antibody (GlaxoSmithKline)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-IL-7Ra antibody (GlaxoSmithKline)
Drug Alias Nameanti-IL-7 receptor alpha chain antibody (GlaxoSmithKline)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin-7 receptors modulators
TargetsInterleukin-7 receptors
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A